Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 3 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 20 |
NetGPI | no | yes: 0, no: 20 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 19 |
GO:0110165 | cellular anatomical entity | 1 | 19 |
Related structures:
AlphaFold database: A4HDL5
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 190 | 192 | PF00675 | 0.467 |
CLV_PCSK_KEX2_1 | 190 | 192 | PF00082 | 0.465 |
DEG_APCC_DBOX_1 | 33 | 41 | PF00400 | 0.571 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.563 |
DOC_CKS1_1 | 149 | 154 | PF01111 | 0.476 |
DOC_CKS1_1 | 156 | 161 | PF01111 | 0.325 |
DOC_CKS1_1 | 55 | 60 | PF01111 | 0.562 |
DOC_CYCLIN_yCln2_LP_2 | 108 | 114 | PF00134 | 0.552 |
DOC_MAPK_gen_1 | 295 | 305 | PF00069 | 0.529 |
DOC_MAPK_MEF2A_6 | 298 | 305 | PF00069 | 0.536 |
DOC_PP2B_LxvP_1 | 108 | 111 | PF13499 | 0.559 |
DOC_PP2B_LxvP_1 | 112 | 115 | PF13499 | 0.544 |
DOC_PP2B_LxvP_1 | 9 | 12 | PF13499 | 0.575 |
DOC_PP4_FxxP_1 | 156 | 159 | PF00568 | 0.250 |
DOC_PP4_FxxP_1 | 55 | 58 | PF00568 | 0.555 |
DOC_WW_Pin1_4 | 148 | 153 | PF00397 | 0.508 |
DOC_WW_Pin1_4 | 155 | 160 | PF00397 | 0.340 |
DOC_WW_Pin1_4 | 54 | 59 | PF00397 | 0.573 |
DOC_WW_Pin1_4 | 71 | 76 | PF00397 | 0.567 |
DOC_WW_Pin1_4 | 93 | 98 | PF00397 | 0.582 |
LIG_14-3-3_CanoR_1 | 190 | 196 | PF00244 | 0.228 |
LIG_14-3-3_CanoR_1 | 34 | 38 | PF00244 | 0.569 |
LIG_BRCT_BRCA1_1 | 4 | 8 | PF00533 | 0.581 |
LIG_eIF4E_1 | 45 | 51 | PF01652 | 0.557 |
LIG_eIF4E_1 | 64 | 70 | PF01652 | 0.535 |
LIG_FHA_1 | 45 | 51 | PF00498 | 0.562 |
LIG_FHA_1 | 98 | 104 | PF00498 | 0.585 |
LIG_LIR_Apic_2 | 153 | 159 | PF02991 | 0.248 |
LIG_LIR_Apic_2 | 291 | 296 | PF02991 | 0.487 |
LIG_LIR_Apic_2 | 52 | 58 | PF02991 | 0.557 |
LIG_LIR_Gen_1 | 135 | 143 | PF02991 | 0.249 |
LIG_LIR_Gen_1 | 244 | 252 | PF02991 | 0.245 |
LIG_LIR_Gen_1 | 268 | 276 | PF02991 | 0.342 |
LIG_LIR_Gen_1 | 5 | 14 | PF02991 | 0.575 |
LIG_LIR_LC3C_4 | 98 | 103 | PF02991 | 0.582 |
LIG_LIR_Nem_3 | 135 | 139 | PF02991 | 0.256 |
LIG_LIR_Nem_3 | 244 | 248 | PF02991 | 0.221 |
LIG_LIR_Nem_3 | 250 | 255 | PF02991 | 0.219 |
LIG_LIR_Nem_3 | 5 | 11 | PF02991 | 0.582 |
LIG_LYPXL_yS_3 | 65 | 68 | PF13949 | 0.543 |
LIG_MYND_1 | 110 | 114 | PF01753 | 0.541 |
LIG_Pex14_1 | 144 | 148 | PF04695 | 0.212 |
LIG_Pex14_2 | 51 | 55 | PF04695 | 0.556 |
LIG_SH2_CRK | 252 | 256 | PF00017 | 0.204 |
LIG_SH2_STAT5 | 130 | 133 | PF00017 | 0.407 |
LIG_SH2_STAT5 | 164 | 167 | PF00017 | 0.242 |
LIG_SH2_STAT5 | 267 | 270 | PF00017 | 0.242 |
LIG_SH3_3 | 107 | 113 | PF00018 | 0.567 |
LIG_SH3_3 | 146 | 152 | PF00018 | 0.354 |
LIG_SH3_3 | 233 | 239 | PF00018 | 0.211 |
LIG_SUMO_SIM_anti_2 | 98 | 105 | PF11976 | 0.580 |
LIG_SUMO_SIM_par_1 | 225 | 230 | PF11976 | 0.406 |
LIG_SUMO_SIM_par_1 | 271 | 277 | PF11976 | 0.211 |
LIG_SUMO_SIM_par_1 | 281 | 286 | PF11976 | 0.216 |
LIG_TRAF2_1 | 297 | 300 | PF00917 | 0.602 |
LIG_TYR_ITIM | 63 | 68 | PF00017 | 0.548 |
LIG_WRC_WIRS_1 | 169 | 174 | PF05994 | 0.204 |
LIG_WRC_WIRS_1 | 228 | 233 | PF05994 | 0.216 |
LIG_WW_2 | 110 | 113 | PF00397 | 0.541 |
LIG_WW_3 | 295 | 299 | PF00397 | 0.519 |
MOD_CK1_1 | 43 | 49 | PF00069 | 0.558 |
MOD_CK1_1 | 96 | 102 | PF00069 | 0.588 |
MOD_GlcNHglycan | 205 | 208 | PF01048 | 0.224 |
MOD_GSK3_1 | 128 | 135 | PF00069 | 0.404 |
MOD_GSK3_1 | 40 | 47 | PF00069 | 0.570 |
MOD_GSK3_1 | 93 | 100 | PF00069 | 0.571 |
MOD_N-GLC_1 | 291 | 296 | PF02516 | 0.362 |
MOD_NEK2_1 | 134 | 139 | PF00069 | 0.273 |
MOD_NEK2_1 | 218 | 223 | PF00069 | 0.469 |
MOD_NEK2_1 | 274 | 279 | PF00069 | 0.234 |
MOD_NEK2_1 | 288 | 293 | PF00069 | 0.360 |
MOD_NEK2_1 | 78 | 83 | PF00069 | 0.540 |
MOD_NEK2_1 | 88 | 93 | PF00069 | 0.564 |
MOD_NEK2_2 | 247 | 252 | PF00069 | 0.222 |
MOD_OFUCOSY | 38 | 44 | PF10250 | 0.370 |
MOD_PIKK_1 | 218 | 224 | PF00454 | 0.212 |
MOD_PIKK_1 | 91 | 97 | PF00454 | 0.573 |
MOD_PKA_1 | 190 | 196 | PF00069 | 0.207 |
MOD_PKA_2 | 189 | 195 | PF00069 | 0.242 |
MOD_PKA_2 | 33 | 39 | PF00069 | 0.570 |
MOD_PKA_2 | 40 | 46 | PF00069 | 0.561 |
MOD_Plk_1 | 97 | 103 | PF00069 | 0.577 |
MOD_Plk_4 | 162 | 168 | PF00069 | 0.410 |
MOD_Plk_4 | 247 | 253 | PF00069 | 0.295 |
MOD_Plk_4 | 283 | 289 | PF00069 | 0.278 |
MOD_Plk_4 | 46 | 52 | PF00069 | 0.560 |
MOD_Plk_4 | 97 | 103 | PF00069 | 0.585 |
MOD_ProDKin_1 | 148 | 154 | PF00069 | 0.508 |
MOD_ProDKin_1 | 155 | 161 | PF00069 | 0.340 |
MOD_ProDKin_1 | 54 | 60 | PF00069 | 0.575 |
MOD_ProDKin_1 | 71 | 77 | PF00069 | 0.566 |
MOD_ProDKin_1 | 93 | 99 | PF00069 | 0.583 |
TRG_ENDOCYTIC_2 | 169 | 172 | PF00928 | 0.240 |
TRG_ENDOCYTIC_2 | 252 | 255 | PF00928 | 0.204 |
TRG_ENDOCYTIC_2 | 65 | 68 | PF00928 | 0.549 |
TRG_ER_diArg_1 | 39 | 42 | PF00400 | 0.575 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A381MTC7 | Leishmania infantum | 28% | 100% |
A0A3Q8IFH7 | Leishmania donovani | 28% | 100% |
A0A3Q8IHZ6 | Leishmania donovani | 25% | 100% |
A0A3S7X7E5 | Leishmania donovani | 26% | 100% |
A0A3S7X7M4 | Leishmania donovani | 25% | 100% |
A0A3S7X7U1 | Leishmania donovani | 25% | 100% |
A0A3S7X7W2 | Leishmania donovani | 27% | 100% |
A4HDI3 | Leishmania braziliensis | 39% | 100% |
A4I0W6 | Leishmania infantum | 60% | 100% |
A4I9X0 | Leishmania infantum | 27% | 100% |
D0A843 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 24% | 68% |
E8NHE0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 100% |
E8NHP0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 30% | 100% |
E9AHT2 | Leishmania infantum | 26% | 100% |
E9ASP7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 30% | 100% |
E9B4Y3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 31% | 100% |
Q4Q325 | Leishmania major | 23% | 100% |
Q4Q397 | Leishmania major | 27% | 100% |
Q4Q3F7 | Leishmania major | 25% | 100% |